Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey

Frequencies of prostate‐specific antigen (PSA) test administration were not actively monitored on a national level during the first decade of PSA testing. The objectives of this article were to reconstruct patterns of PSA testing between black and white men in the US and to determine the extent of any racial disparity in PSA use.

[1]  E. Feuer,et al.  Modeling the dissemination of mammography in the United States , 2005, Cancer Causes & Control.

[2]  Pamela A. Shaw,et al.  Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. , 2002, Urology.

[3]  Harry J de Koning,et al.  Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial , 2002, International journal of cancer.

[4]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[5]  Peter H Gann,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.

[6]  Ruth Etzioni,et al.  Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. , 2004, Urology.

[7]  Binbing Yu,et al.  Estimation of shared Gamma frailty models by a modified EM algorithm , 2006, Comput. Stat. Data Anal..

[8]  E. Feuer,et al.  Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates , 2002, Cancer.

[9]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[10]  N. Brown,et al.  Forward telescoping: the question matters. , 1998, Memory.

[11]  Barnett S Kramer,et al.  Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial. , 2005, The Journal of urology.

[12]  O. Brawley,et al.  The epidemiology of prostate cancer part I: descriptive epidemiology. , 1998, Seminars in urologic oncology.

[13]  E. Feuer,et al.  The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States , 1998, Cancer Causes & Control.

[14]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.